A new study has found that consuming sugary foods and drinks like smoothies can increase the gastrointestinal side effects ...

This story was originally published in 2016 and was most recently updated in September 2026. Testicular cancer develops when normal cells in one or both testicles begin to grow out of control.

Not all thyroid nodules are the same, and neither are their treatments. Most are not cancer. MSK thyroid experts can give you an accurate diagnosis and choose the best treatment. The thyroid is a ...

Thoracic oncologist Kathryn Arbour, MD, led the Phase 1/2 clinical trial of daraxonrasib at MSK for metastatic lung cancer. The drug was approved by the FDA for pancreatic cancer in August 2026 and Dr ...

Memorial Sloan Kettering Cancer Center (MSK) has again been recognized among the nation’s very best, earning the distinction as the top cancer center in the Northeast and in the New York metropolitan ...

Why is this latest selpercatinib approval important? “The new FDA approval is the latest example of how the EDD Service at MSK can make a difference for patients everywhere, not just those being ...

Some cancer treatments, including chemotherapy and radiation therapy to the head and neck, may affect the cells that are in your mouth and digestive tract. This is known as mucositis (myoo-koh-SY-tis) ...

For people living with advanced triple-negative breast cancer (TNBC), a newly approved treatment may offer more time and a better quality of life. TNBC makes up about 10% to 20% of all breast cancers, ...

This information explains how to care for your wound after your skin procedure with sutures (stitches).

Memorial Sloan Kettering Cancer Center today announced that Shakeeb Akhter has joined MSK as its new Chief Digital Officer.

Finding the right cancer care team can be stressful. Your team of anal cancer experts will ask about your treatment goals and choose the best treatments for you. Your care team will include anal ...

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.